KIR Donor Selection: Feasibility in Identifying Better Donors

We previously reported that AML transplants using KIR B haplotype Better or Best (≥2 B activating gene loci ± Cen B/B) unrelated donors (URD) yield less relapse and better survival. In this prospective trial we evaluated 535 AML searches from 14 participating centers with centralized donor KIR genot...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biol Blood Marrow Transplant
Autori principali: Weisdorf, Daniel, Cooley, Sarah, Wang, Tao, Trachtenberg, Elizabeth, Haagenson, Michael D., Vierra-Green, Cynthia, Spellman, Stephen, Spahn, Ashley, Vogel, Jenny, Kobusingye, Hati, Fehninger, Todd, Woolfrey, Ann, Devine, Steven, Ross, Maureen, Waller, Edmund K., Sobecks, Ronald, Parham, Peter, Guethlein, Lisbeth A, GE Marsh, Steven, Miller, Jeffrey
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6310641/
https://ncbi.nlm.nih.gov/pubmed/30149149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2018.08.022
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi